Drugs & Pharmacology Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Condition: IgA Nephropathy and Focal Segmental Glomerulosclerosis Interventions: Drug: HS-10390 tablet; Drug: Placebo tablet Sponsor: Hansoh BioMedical R&D Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Conditions: IgA Nephropathy; Focal Segmental Glomerulosclerosis Interventions: Drug: HS-10390 tablet; Drug: Placebo tablet Sponsor: Hansoh BioMedical R&D Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Condition: IgA Nephropathy and Focal Segmental Glomerulosclerosis Interventions: Drug: HS-10390 tablet; Drug: Placebo tablet Sponsor: Hansoh BioMedical R&D Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
